GridAI Technologies (GRDX) Other Operating Expenses (2021 - 2023)
GridAI Technologies' (GRDX) quarterly Other Operating Expenses came in at $4.5 million in Q4 2023, up 156.07% on a QoQ basis from -$8.1 million in Q3 2022.
GridAI Technologies (GRDX) Other Operating Expenses (2021 - 2023) Analysis & Trends
GridAI Technologies (GRDX) has 3 years of Other Operating Expenses data on file, last reported at $4.5 million in Q4 2023.
- Quarterly Other Operating Expenses changed N/A year-over-year to $4.5 million in Q4 2023, while the trailing twelve-month figure through Sep 2024 was $4.5 million (changed N/A YoY) and the FY2023 annual result came in at $4.5 million, up 156.07% from the prior year.
- Other Operating Expenses climbed to $4.5 million in Q4 2023, from -$8.1 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $4.5 million in Q4 2023 to a low of -$8.1 million in Q3 2022.
- A 3-year average of -$754868.5 and a median of $266176.5 in 2021 frame the typical range for Other Operating Expenses.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | GridAI Technologies | 5.82 Mn | 5.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 4.53 Mn |
| Sep 30, 2022 | -8.09 Mn |
| Jun 30, 2021 | -300.00 |
| Mar 31, 2021 | 532,653.00 |